Kirsten E. Smith

1.5k total citations
37 papers, 1.0k citations indexed

About

Kirsten E. Smith is a scholar working on Pharmacology, Biochemistry and Organic Chemistry. According to data from OpenAlex, Kirsten E. Smith has authored 37 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pharmacology, 15 papers in Biochemistry and 14 papers in Organic Chemistry. Recurrent topics in Kirsten E. Smith's work include Alkaloids: synthesis and pharmacology (22 papers), Traditional and Medicinal Uses of Annonaceae (15 papers) and Chemical synthesis and alkaloids (14 papers). Kirsten E. Smith is often cited by papers focused on Alkaloids: synthesis and pharmacology (22 papers), Traditional and Medicinal Uses of Annonaceae (15 papers) and Chemical synthesis and alkaloids (14 papers). Kirsten E. Smith collaborates with scholars based in United States, United Kingdom and Malaysia. Kirsten E. Smith's co-authors include Kelly E. Dunn, Albert Garcia‐Romeu, David H. Epstein, Oliver Grundmann, Jeffrey M. Rogers, Justin C. Strickland, David J. Cox, Roland R. Griffiths, Christopher R. McCurdy and Charles A. Veltri and has published in prestigious journals such as Preventive Medicine, Atherosclerosis and Drug and Alcohol Dependence.

In The Last Decade

Kirsten E. Smith

37 papers receiving 978 citations

Peers

Kirsten E. Smith
Reginald V. Fant United States
Kirsten E. Smith
Citations per year, relative to Kirsten E. Smith Kirsten E. Smith (= 1×) peers Reginald V. Fant

Countries citing papers authored by Kirsten E. Smith

Since Specialization
Citations

This map shows the geographic impact of Kirsten E. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kirsten E. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kirsten E. Smith more than expected).

Fields of papers citing papers by Kirsten E. Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kirsten E. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kirsten E. Smith. The network helps show where Kirsten E. Smith may publish in the future.

Co-authorship network of co-authors of Kirsten E. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Kirsten E. Smith. A scholar is included among the top collaborators of Kirsten E. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kirsten E. Smith. Kirsten E. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sharma, Abhisheak, Kirsten E. Smith, Erin C. Berthold, et al.. (2025). Chemical Analysis and Alkaloid Intake for Kratom Products Available in the United States. Drug Testing and Analysis. 17(10). 1974–1984. 5 indexed citations
2.
Rogers, Jeffrey M., Stephanie T. Weiss, David H. Epstein, et al.. (2024). Kratom addiction per DSM-5 SUD criteria, and kratom physical dependence: Insights from dosing amount versus frequency. Drug and Alcohol Dependence. 260. 111329–111329. 10 indexed citations
3.
Smith, Kirsten E., David H. Epstein, & Stephanie T. Weiss. (2024). Controversies in Assessment, Diagnosis, and Treatment of Kratom Use Disorder. Current Psychiatry Reports. 26(9). 487–496. 4 indexed citations
4.
Hill, Katherine, et al.. (2024). Prevalence of Kratom Use Disorder Among Kratom Consumers. Journal of Addiction Medicine. 18(3). 306–312. 7 indexed citations
5.
Henningfield, Jack E., Oliver Grundmann, Marilyn A. Huestis, & Kirsten E. Smith. (2024). Kratom safety and toxicology in the public health context: research needs to better inform regulation. Frontiers in Pharmacology. 15. 1403140–1403140. 12 indexed citations
6.
Smith, Kirsten E., Kelly E. Dunn, Christopher R. McCurdy, et al.. (2023). Examining the paradoxical effects of kratom: a narrative inquiry. Frontiers in Pharmacology. 14. 1174139–1174139. 20 indexed citations
7.
Grundmann, Oliver, Charles A. Veltri, Kirsten E. Smith, et al.. (2022). Exploring the self-reported motivations of kratom (Mitragyna speciosa Korth.) use: a cross-sectional investigation. The American Journal of Drug and Alcohol Abuse. 48(4). 433–444. 33 indexed citations
8.
Smith, Kirsten E., Jeffrey M. Rogers, Kelly E. Dunn, et al.. (2022). Searching for a Signal: Self-Reported Kratom Dose-Effect Relationships Among a Sample of US Adults With Regular Kratom Use Histories. Frontiers in Pharmacology. 13. 765917–765917. 37 indexed citations
9.
Smith, Kirsten E., Kelly E. Dunn, Jeffrey M. Rogers, et al.. (2022). Assessment of Kratom Use Disorder and Withdrawal Among an Online Convenience Sample of US Adults. Journal of Addiction Medicine. 16(6). 666–670. 29 indexed citations
10.
Smith, Kirsten E., et al.. (2021). Potential Value of the Insights and Lived Experiences of Addiction Researchers With Addiction. Journal of Addiction Medicine. 16(2). 135–137. 19 indexed citations
11.
Strickland, Justin C., William W. Stoops, Kelly E. Dunn, Kirsten E. Smith, & Jennifer R. Havens. (2021). The continued rise of methamphetamine use among people who use heroin in the United States. Drug and Alcohol Dependence. 225. 108750–108750. 42 indexed citations
12.
Smith, Kirsten E., et al.. (2020). Characterization of diverted buprenorphine use among adults entering corrections-based drug treatment in Kentucky. Drug and Alcohol Dependence. 208. 107837–107837. 11 indexed citations
13.
Garcia‐Romeu, Albert, David J. Cox, Kirsten E. Smith, Kelly E. Dunn, & Roland R. Griffiths. (2020). Kratom (Mitragyna speciosa): User demographics, use patterns, and implications for the opioid epidemic. Drug and Alcohol Dependence. 208. 107849–107849. 125 indexed citations
14.
Smith, Kirsten E., et al.. (2019). Non-Prescribed Buprenorphine Use Mediates the Relationship between Heroin Use and Kratom Use among a Sample of Polysubstance Users. Journal of Psychoactive Drugs. 51(4). 311–322. 9 indexed citations
15.
Smith, Kirsten E., Amanda M. Bunting, Seana Golder, et al.. (2019). Prevalence and Correlates of Disability Among a Sample of Victimized Women on Probation and Parole. Journal of Correctional Health Care. 25(2). 143–161. 3 indexed citations
16.
Buros, Amy, et al.. (2019). Self-reported Health Diagnoses and Demographic Correlates With Kratom Use: Results From an Online Survey. Journal of Addiction Medicine. 14(3). 244–252. 40 indexed citations
17.
Smith, Kirsten E. & William W. Stoops. (2019). Synthetic Cathinone Use Among Polysubstance Users: Indirect Indicator of Indiscriminate Drug Taking or Preferred Drug of Abuse?. Journal of Drug Issues. 49(2). 369–386. 5 indexed citations
19.
Parsons, Tessa J., Claudio Sartini, Elizabeth A. Ellins, et al.. (2016). Objectively measured physical activity and sedentary behaviour and ankle brachial index: Cross-sectional and longitudinal associations in older men. Atherosclerosis. 247. 28–34. 28 indexed citations
20.
Parsons, Tessa J., Claudio Sartini, Elizabeth A. Ellins, et al.. (2016). Objectively measured physical activity, sedentary time and subclinical vascular disease: Cross-sectional study in older British men. Preventive Medicine. 89. 194–199. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026